The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(5-(2-Cyclopropylethyl)-4-(3-fluoro-4-sulfamoylbenzyl)-3-(3-((5-methylthiophen-3-yl)ethynyl)phenyl)-1H-pyrazol-1-yl)thiazole-4-carboxylic Acid ID: ALA4744588
PubChem CID: 162649041
Max Phase: Preclinical
Molecular Formula: C32H26F2N4O4S3
Molecular Weight: 664.78
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C#Cc2cc(-c3nn(-c4nc(C(=O)O)cs4)c(CCC4CC4)c3Cc3ccc(S(N)(=O)=O)c(F)c3)ccc2F)cs1
Standard InChI: InChI=1S/C32H26F2N4O4S3/c1-18-12-21(16-43-18)4-7-22-15-23(8-9-25(22)33)30-24(13-20-6-11-29(26(34)14-20)45(35,41)42)28(10-5-19-2-3-19)38(37-30)32-36-27(17-44-32)31(39)40/h6,8-9,11-12,14-17,19H,2-3,5,10,13H2,1H3,(H,39,40)(H2,35,41,42)
Standard InChI Key: ZAGPASSCPKKTBO-UHFFFAOYSA-N
Molfile:
RDKit 2D
45 50 0 0 0 0 0 0 0 0999 V2000
39.4811 -1.3248 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.2983 -1.3290 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
39.8932 -0.6192 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.0069 -5.5553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8241 -5.5553 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.0785 -4.7786 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.4155 -4.2964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7568 -4.7786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8583 -4.5238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5187 -5.0050 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
45.1805 -4.5256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9291 -3.7480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1119 -3.7470 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.9794 -4.5264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8092 -3.7271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4181 -3.1809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2483 -2.3823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4703 -2.1295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8619 -2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0348 -3.4779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4143 -3.4793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1213 -3.0696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5262 -6.2127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7127 -6.1248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2317 -6.7845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5630 -7.5325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3801 -7.6168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8575 -6.9561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.4103 -3.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.2229 -3.1740 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
45.0789 -2.3405 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.0837 -2.4319 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
40.9053 -0.7826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.4191 -6.6970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0827 -8.1936 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
43.1201 -2.2524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5270 -1.5475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7098 -1.5487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6063 -6.6095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7938 -6.5220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3854 -5.8189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5856 -5.9868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4982 -6.7994 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
37.2439 -7.1335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9797 -5.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 4 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 2 0
6 9 1 0
8 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
7 21 1 0
21 22 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
4 23 1 0
12 29 1 0
29 30 1 0
29 31 2 0
19 32 1 0
18 2 1 0
2 33 1 0
25 34 1 0
26 35 1 0
22 36 1 0
37 36 1 0
38 37 1 0
36 38 1 0
34 39 3 0
39 40 1 0
40 41 1 0
41 42 2 0
42 43 1 0
43 44 1 0
44 40 2 0
42 45 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 664.78Molecular Weight (Monoisotopic): 664.1084AlogP: 6.32#Rotatable Bonds: 9Polar Surface Area: 128.17Molecular Species: ACIDHBA: 8HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.17CX Basic pKa: 1.39CX LogP: 8.32CX LogD: 4.98Aromatic Rings: 5Heavy Atoms: 45QED Weighted: 0.18Np Likeness Score: -1.32
References 1. Rai G,Urban DJ,Mott BT,Hu X,Yang SM,Benavides GA,Johnson MS,Squadrito GL,Brimacombe KR,Lee TD,Cheff DM,Zhu H,Henderson MJ,Pohida K,Sulikowski GA,Dranow DM,Kabir M,Shah P,Padilha E,Tao D,Fang Y,Christov PP,Kim K,Jana S,Muttil P,Anderson T,Kunda NK,Hathaway HJ,Kusewitt DF,Oshima N,Cherukuri M,Davies DR,Norenberg JP,Sklar LA,Moore WJ,Dang CV,Stott GM,Neckers L,Flint AJ,Darley-Usmar VM,Simeonov A,Waterson AG,Jadhav A,Hall MD,Maloney DJ. (2020) Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties., 63 (19.0): [PMID:32902275 ] [10.1021/acs.jmedchem.0c00916 ]